These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14626982)

  • 41. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-58. PubMed ID: 20213918
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA
    Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA regulation of Internet pharmaceutical communications: strategies for improvement.
    Loza EL
    Food Drug Law J; 2000; 55(2):269-92. PubMed ID: 12269369
    [No Abstract]   [Full Text] [Related]  

  • 44. GATT implementation and generic drug approval.
    Safir PO; Lassman SM
    Food Drug Law J; 1996; 51(2):295-302. PubMed ID: 11820203
    [No Abstract]   [Full Text] [Related]  

  • 45. Two views of the emperor's new clones.
    Miller HI
    Nat Biotechnol; 2007 Mar; 25(3):281. PubMed ID: 17344872
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 47. Federal appeals court says no to first amendment claim in telemarketing case.
    Sfikas PM
    J Am Dent Assoc; 2006 Feb; 137(2):241-2. PubMed ID: 16521392
    [No Abstract]   [Full Text] [Related]  

  • 48. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 49. The tobacco industry and the First Amendment: an analysis of the 1998 Master Settlement Agreement.
    Luka LA
    J Law Health; 1999-2000; 14(2):297-319. PubMed ID: 11499160
    [No Abstract]   [Full Text] [Related]  

  • 50. Court rules dentists to be judged by standards of honest marketplace.
    Plunkett LR
    N Y State Dent J; 1999; 65(6):6-8. PubMed ID: 10474991
    [No Abstract]   [Full Text] [Related]  

  • 51. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Mar; 75(53):13225-32. PubMed ID: 20383919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002.
    Cooper KJ
    Food Drug Law J; 2002; 57(3):519-44. PubMed ID: 12710409
    [No Abstract]   [Full Text] [Related]  

  • 53. Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?
    Patsner B
    Food Drug Law J; 2009; 64(1):1-41. PubMed ID: 19998571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prohibited acts and enforcement tools.
    Mathewson NW
    Food Drug Law J; 2010; 65(3):545-54. PubMed ID: 24479241
    [No Abstract]   [Full Text] [Related]  

  • 55. The Family Smoking Prevention and Tobacco Control Act and the First Amendment: why a substantial interest in protecting public health won't save some new restrictions on tobacco advertising.
    Stoll E
    Food Drug Law J; 2010; 65(4):873-900, iii. PubMed ID: 24479250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tobacco industry strategies to oppose federal regulation.
    Arno PS; Brandt AM; Gostin LO; Morgan J
    JAMA; 1996 Apr; 275(16):1258-62. PubMed ID: 8601958
    [No Abstract]   [Full Text] [Related]  

  • 57. The Food and Drug Administration v. the First Amendment: a survey of recent FDA enforcement.
    Masoudi G; Pruitt C
    Health Matrix Clevel; 2011; 21(1):111-47. PubMed ID: 21847899
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 59. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.